Picture this: a beloved pop star, once part of the chart-topping sensation Little Mix, brings two precious daughters into the world prematurely, only to face the shattering reality that they might never take their first steps due to a devastating genetic disorder. That's the heart-wrenching story of Jesy Nelson, who courageously shared her family's ordeal in a recent Instagram video. But here's where it gets really emotional—her twins' condition could shorten their lives dramatically if not addressed swiftly. Let's dive deeper into this touching tale, exploring the challenges, the hope, and the broader implications that might just surprise you.
Just over 46 minutes ago, Noor Nanji, the BBC's culture correspondent, reported on Jesy Nelson, the former Little Mix vocalist, who opened up about her twin baby daughters, Ocean Jade and Story Monroe Nelson-Foster. These little ones arrived early last May, the result of Jesy's union with musician Zion Foster. In a heartfelt Sunday post, Jesy revealed that her girls have been diagnosed with Spinal Muscular Atrophy (SMA), which she described as the harshest form of muscular disease imaginable. To help beginners grasp this, SMA is a rare genetic condition that attacks the nerves controlling muscles, leading to progressive weakness and wasting. It impacts every muscle in the body—from the legs and arms to even the vital functions like breathing and swallowing.
In her video, which you can watch via this link (https://www.instagram.com/reel/DTFcIARCLE1/?igsh=MThyYnAwam1yMXBiMA==), Jesy recounted how the twins weren't moving their legs as much as expected and struggled with feeding. After what she called the most grueling three or four months, filled with countless doctor's visits, the diagnosis came: SMA type 1, the most severe variant. Essentially, this disease gradually destroys muscle function, and without prompt intervention, it can tragically reduce a baby's life expectancy to under two years. Think of it like a silent thief that steals strength over time, leaving the body vulnerable in ways that affect everything from basic motor skills to essential bodily processes.
Jesy explained that the assessment happened at the renowned Great Ormond Street Hospital in London, where specialists delivered the tough news: her daughters would likely never walk or regain the strength in their necks, meaning they'd face lifelong disabilities. Yet, amidst the sorrow, there's a glimmer of gratitude— the girls have received treatment, and Jesy expressed immense thanks for it, noting that without it, the outcome could have been fatal. She's even stepped into a nursing role, helping to manage her daughters' care, including using breathing machines to support their fragile respiration.
The video's purpose, Jesy said, was to process the 'heartbreaking' last three months that flipped her world upside down. But she remains optimistic, believing her daughters will 'defy the odds' with proper support and fight back against this relentless foe. By sharing their story, she's hoping to speed up diagnoses for other kids, potentially saving lives through early action. And this is the part most people miss—the power of personal stories in driving change, turning private pain into public awareness.
Adding to her journey, Jesy, now 34, shared in an October Instagram post that she'd never felt prouder of her body after the twins' premature birth at 31 weeks, despite rare pregnancy complications. Becoming a mother, she said, highlighted just how resilient her body truly is. Before this chapter, Jesy stepped away from Little Mix in December 2020 and embarked on a solo career, releasing hits like the 2021 single 'Boyz' featuring Nicki Minaj.
To understand SMA better for those new to this, it's a progressive neuromuscular disorder caused by a faulty gene that diminishes the body's ability to produce a protein essential for nerve cells supporting muscles. Symptoms often appear in infancy, as seen with Jesy's twins, and without treatment, it can lead to severe weakness, respiratory failure, and sadly, early death. But here's where it gets controversial—while gene therapy offers hope, is it fair that access depends on timing and resources? In 2021, the NHS approved Zolgensma, a groundbreaking gene therapy drug that introduces a healthy gene copy to combat the issue. As explained on the BBC's health page (https://www.bbc.co.uk/news/health-56315870), this treatment works by delivering the corrected gene, but it must be administered before irreversible nerve damage sets in, making early detection crucial.
According to SMA UK, the charity advocating for those affected, there's a pressing call to include SMA in the standard newborn blood spot test, which currently screens for 10 other rare conditions. Right now, testing is limited to babies with a sibling who has SMA. The charity estimates that around 47 infants in the UK were born with the condition in 2024, though about one in 40 people unknowingly carry the altered gene that could lead to it in their offspring. Imagine the difference if every newborn was checked—potentially catching cases before symptoms worsen, but does this mean we should expand screening universally, or does it raise privacy concerns? This is a debate worth having.
In wrapping up, Jesy's story underscores the urgency of awareness and early intervention for SMA. Yet, it also sparks bigger questions: Should society prioritize funding for such therapies, or invest more in prevention through widespread genetic screening? And here's a thought-provoking one for you—what if advancing treatments like Zolgensma lead to ethical dilemmas, like who gets access first? Do you agree that SMA deserves a spot in routine newborn checks, or do you see potential downsides? We'd love to hear your opinions in the comments—share your take and let's discuss!
